# Seeing Medicines

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/seeing-medicines

- Industry: Biotechnology
- Headquarters: Arden, US
- Website: www.seeingmedicines.com
- Total disclosed funding: $6M
- Latest round: Seed (Jun 11, 2021)
- Investors on record: 1

## About

Based in North Carolina, US, and founded in 2020, Seeing Medicines, Inc. develops regenerative medicine treatments to restore and maintain vision in people with macular degenerative diseases. Leroux Jooste is the CEO and President of the company as of 2021. In June 2021, the company raised nearly USD 7 million in equity funding from three investors.

The company is developing novel cellular therapeutics to treat AMD (Age-related Macular Degeneration), Best Disease, Stargardt Disease, and other macular degenerative illnesses. SMI-001, a comprehensive therapy system for macular degeneration illnesses, is the company's flagship product.

Seeing Medicines, Inc. plans to use the equity funding raised in June 2021 to help people with macular degeneration.

## Funding rounds

- Seed, Jun 11, 2021, $6M — Sante Ventures

## Investors

- Sante Ventures (https://capitalatlas.ai/funds/sante-ventures) — Seed